Order results by:
| Issue | Title | |
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... therapy in high doses is discussed in patients with IHD and dyslipidemia. Atorvastatin in high doses ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... recommended for maintenance of sinus rhythm in paroxysmal AF and atorvastatin (average dose 23.5±3.7 mg/day ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy ..." | ||
| Vol 6, No 4 (2010) | RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| M. V. Ezhov | ||
| "... doses are presented. In these studies high dose atorvastatin therapy was used in patients with acute ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... with STEMI. Main group patients immediately prior to sheath insertion took atorvastatin at a high dose (80 mg ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic ..." | ||
| Vol 1, No 3 (2005) | PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE | Abstract similar documents |
| V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova | ||
| "... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..." | ||
| Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
| A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
| "... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... high (269, 90.3%) CVR. All patients were recommended to take the reproduced drugs of atorvastatin ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... of AF after CABG in patients with IHD. At that, the efficacy of atorvastatin therapy correlated ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... .9%, respectively. Average dose of statins (in conversion to atorvastatin) increased from 10 mg to 20 mg in high ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..." | ||
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| "... of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| Vol 1, No 3 (2005) | EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim | ||
| "... by randomization. Initial dose of both drugs was 10 mg daily. Dose was adjusted after 3 weeks. The dose ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... - from 74% to 96%. However, some drugs (statins) have been used in inadequate doses. Low-density ..." | ||
| Vol 10, No 4 (2014) | STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN | Abstract similar documents |
| N. G. Gogolashvili | ||
| "... The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction ..." | ||
| Vol 13, No 4 (2017) | HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? | Abstract similar documents |
| I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova | ||
| "... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... on the efficacy of atorvastatin therapy and the incidence of the combined endpoint in patients after myocardial ..." | ||
| Vol 4, No 5 (2008) | EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released ..." | ||
| Vol 2, No 2 (2006) | METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS | Abstract similar documents |
| N. V. Perova, I. N. Ozerova, V. A. Metelskaya | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| "... perindopril,rosuvastatin and fixed-dose combination of perindopril and indapamide, in ambulatory patients ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... up to 8.3%. When choosing among statins specialists recommended significantly more often atorvastatin ..." | ||
| Vol 8, No 1 (2012) | THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov | ||
| "... . The efficacy of high-dose simvastatin (40 mg/day) therapy initiated in acute stage of ischemic stroke ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... (63.8%). No significant differences were found in daily doses of the main prescribed preventive drugs ..." | ||
| Vol 7, No 4 (2011) | SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS | Abstract similar documents |
| E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts | ||
| "... Aim. To study the relations of clinical characteristics and individual warfarin dose titration ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... .39%, statins – 69.45%). When assessing prescribed doses of drugs, an increase in a number of their higher doses ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... efficacy and safety both in full dose and reasonably reduced dosage has been proved, including older ..." | ||
| Vol 2, No 1 (2006) | SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) | Abstract similar documents |
| I. A. Latfullin, R. F. Gaifullina | ||
| "... intensity in IHD patients was decreasing while nibentan dose was growing. Histological study of auricular ..." | ||
| Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
| "... in this process. Low doses of direct oral inhibitors of thrombin are able to potentiate antithrombotic effect ..." | ||
| Vol 10, No 6 (2014) | DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) | Abstract similar documents |
| A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov | ||
| "... only to 17.8% of them. Statins were mainly recommended in moderate doses; only one patient took ..." | ||
| Vol 7, No 5 (2011) | HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY | similar documents |
| G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio | ||
| "... стандартной дозами клопидогрела на агрегацию тромбоцитов, воспаление и функцию эндотелия у больных, перенесших ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... the possible benefits of statin therapy in fixed doses for primary and secondary prevention of cardiovascular ..." | ||
| Vol 3, No 4 (2007) | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE | Abstract similar documents |
| I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko | ||
| "... and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF) Material ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... , hypolipidemic therapy with atorvastatin 17.0Ѓ}4.7 mg/day and combined hypoglycemic therapy with metformin 1093 ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... in cardioprotective doses [ASA 75 mg+Mg(OH)2 15.2 mg], which differ in the composition of excipients, with a reference ..." | ||
| Vol 2, No 4 (2006) | EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. I. Katelnizkaya, L. A. Chaischeva | ||
| "... patients additionally to basic IHD therapy took enalapril in dose 2,5-30 mg/daily during 12 weeks. Before ..." | ||
| Vol 9, No 6 (2013) | DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. D. Deev, S. A. Boytsov | ||
| "... At the present time ischemic heart disease (IHD) continues to be the leading cause ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... prevention). Group 2 received a titration-free statin regimen in fixed doses (group 2A [n=50] – primary ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| S. Y. Martsevich, J. V. Lukina, A. D. Deev, N. S. Oganisyan, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, V. P. Voronina, M. P. Kozireva | ||
| "... ,5 mg daily or CR 10/6,25 mg daily. Within next 2 weeks doses of drugs were doubled if target BP level ..." | ||
| Vol 15, No 4 (2019) | The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients | Abstract similar documents |
| M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova | ||
| "... Аim. To study the efficacy, tolerability and safety of using a fixed dose combination of an ACE ..." | ||
| Vol 7, No 4 (2011) | EFFECT OF FERROTHERAPY ON COURSE OF ISCHEMIC HEART DISEASE ASSOCIATED WITH MILD IRON DEFICIENCY IN MEN | Abstract similar documents |
| N. S. Belousova, L. V. Frolova, G. E. Chernogoryuk, L. I. Tyukalova | ||
| "... Aim. To assess effect of ferrotherapy on course of ischemic heart disease (IHD) associated ..." | ||
| Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... in a cohort of patients with ischemic heart disease (IHD), confirmed by coronary angiography data, during ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... schemes and the preferred doses of statins and antiplatelet agents depending on the localization ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... . Atorvastatin (Tulip, LEK) 20-40 mg OD was prescribed for HH control. Management of CG patients was performed ..." | ||
| Vol 7, No 5 (2011) | CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov | ||
| "... ) and ischemic heart disease (IHD) in prevention of contrast induced nephropathy (CIN). Material and мethods ..." | ||
| Vol 9, No 5 (2013) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva | ||
| "... Aim. To study the clinical equivalence of the two low-dose combined drugs on the base of generic ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... as the antihypertensive and organoprotective effects of fixed-dose combinations of amlodipine/lisinopril and bisoprolol ..." | ||
| Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
| N. V. Perova | ||
| "... Comparative dose-dependent ability of different statins to lower serum low-density lipoproteins ..." | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... inflammation and to reveal particularities of its usage in ischemic heart disease (IHD) patients with active ..." | ||
| Vol 8, No 2 (2012) | THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev | ||
| "... with stable ischemic heart disease (IHD). Material and methods. Patients (n=120), aged 40–72 (58.7±7.7) years ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF AMLODIPINE AND BISOPROLOL ON CAROTID AND VERTEBRAL BLOOD FLOW IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. D. Golovanova, N. N. Silaeva, D. Y. Kovalev | ||
| "... heart disease (IHD). Material and methods. 135 patients aged 35-90 y.o. were examined. PVR ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... treatment with atorvastatin for the primary prevention of cardiovascular complications in patients ..." | ||
| Vol 12, No 6 (2016) | THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev | ||
| "... ischemic heart disease (IHD) on the quality of life (QoL). Material and methods. Patients with verified ..." | ||
| Vol 10, No 2 (2014) | CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... (IHD) and paroxysmal atrial fibrillation (AF) during treatment with amiodarone 200 mg daily compared ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... , inflammatory factors and endothelium function in patients with ischemic heart disease (IHD). Material ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... with ischemic heart disease (IHD) before and after coronary artery bypass graft (CABG). Material and methods ..." | ||
| Vol 7, No 4 (2011) | VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY | Abstract similar documents |
| L. A. Haisheva, S. V. Shlyk | ||
| "... with arterial hypertension (HT) and ischemic heart disease (IHD), and the possibility of the correction ..." | ||
| Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
| "... processes and endothelial function in elderly patients with ischemic heart disease (IHD). Material ..." | ||
| Vol 9, No 6 (2013) | DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi | ||
| "... (IHD) and persistent atrial fibrillation (AF) compared among those treated with amiodarone 200 mg daily ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... -dose combination with hydrochlorothiazide, including real clinical practice settings. The evidence base ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..." | ||
| Vol 13, No 3 (2017) | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION | Abstract similar documents |
| F. I. Belyalov | ||
| "... The ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse ..." | ||
| Vol 7, No 6 (2011) | DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER | Abstract similar documents |
| I. S. Yavelov | ||
| "... of dabigatran in various doses are discussed. Besides, a comparison of dabigatran and varfarin therapies ..." | ||
| Vol 15, No 6 (2019) | New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease | Abstract similar documents |
| N. B. Perepech | ||
| "... (IHD) are presented in the review. Information on the classes of drugs that improve the prognosis ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... prescribed rosuvastatin therapy when indicated, in accordance with the Guidelines, choosing the dose ..." | ||
| Vol 6, No 4 (2010) | MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION | Abstract similar documents |
| Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova | ||
| "... and relief in patients with ischemic heart disease (IHD) and symptoms of stable angina class 2-3. Material ..." | ||
| Vol 2, No 1 (2006) | PROPAFENONE FOR SINUS RHYTHM RECOVERY AND SUPPORT IN PATIENTS WITH PERSISTENT FORM OF AURICULAR FIBLILLATION. “PROMETHEUS” – OPENED MULTICENTER STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzsky, , , , , , , , , , , , , , , , , | ||
| "... (Propanorm, PRO.MED.CS Praha a.s., Czech Republic) in a single per oral dose of 600 mg for AF paroxysm relief ..." | ||
| Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract similar documents |
| E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..." | ||
| Vol 3, No 2 (2007) | NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS | Abstract similar documents |
| Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin | ||
| "... of control period 50 randomly selected patients began to take nebivolol in initial dose of 5mg once daily ..." | ||
| Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. O. Shevchenko, O. P. Shevchenko | ||
| "... Peculiarities of the mode of action and clinical use of fixed low-dose combination of lisinopril ..." | ||
| Vol 3, No 2 (2007) | VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY | Abstract similar documents |
| D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes | ||
| "... for usage of pharmacogenetics approach for individual choice of indirect anticoagulant dose regime. However ..." | ||
| Vol 16, No 4 (2020) | From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases | Abstract similar documents |
| P. A. Lebedev, A. A. Garanin | ||
| Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
| E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
| "... dose combinations and their efficacy in hypertensive patients in the real outpatient practice ..." | ||
| Vol 5, No 2 (2009) | EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| L. A. Haisheva | ||
| "... hypertension (HT), as well as possibility of their correction by lisinopril or by fixed low dose combination ..." | ||
| Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... patients fixed-dose combinations of antihypertensive drugs as initial therapy. This concept is reflected ..." | ||
| Vol 11, No 2 (2015) | RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE? | Abstract similar documents |
| Yu. I. Grinshtein, V. V. Shabalin | ||
| "... Resistant hypertension is defined as hypertension uncontrolled with optimal doses of three ..." | ||
| Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
| "... and asparagine transaminase levels was included into the initial examination. Rosuvastatin in a fixed dose of 20 ..." | ||
| Vol 4, No 5 (2008) | EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS | Abstract similar documents |
| S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya | ||
| "... therapy or only basic therapy groups. Enalapril dose titration was performed in all patients. Quality ..." | ||
| Vol 17, No 2 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| "... for conversion of AFib and AFl in intense care units in escalating doses (10-30 mcg/kg) intravenously. Primary ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... from Zocor to Simvahexal, G2 patients did not change their therapy. Simvahexal dose was increased to 30 ..." | ||
| Vol 5, No 4 (2009) | DOBUTAMINE STRESS-ECHOCARDIOGRAPHY: POSSIBILITY OF CLINICAL USAGE IN CARDIOLOGY PRACTICE | Abstract similar documents |
| M. A. Saidova | ||
| "... of patient examination to reveal latent ischemic heart disease (IHD). That is one of the mostly informative ..." | ||
| Vol 13, No 1 (2017) | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. Yu. Shimohina, M. M. Petrova, A. A. Savchenko, M. S. Chernyaeva | ||
| "... of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepressant therapy ..." | ||
| Vol 10, No 6 (2014) | «MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION | Abstract similar documents |
| S. R. Gilyarevskiy | ||
| "... The significance of verapamil in the treatment of patients with ischemic heart disease (IHD ..." | ||
| Vol 7, No 1 (2011) | ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov | ||
| "... to standard treatment of the underlying disease and oral anticoagulants. The first dose of propafenone was 300 ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... clopidogrel daily dose was increased to 150 mg for the whole next period of observation. Patients randomized ..." | ||
| Vol 17, No 3 (2021) | Ability of Evaluation Coronary Calcium Index Based on Ultra-Low-Dose Computed Tomography Used in Moscow Lung Cancer Screening Project | Abstract similar documents |
| A. E. Nikolaev, A. N. Shapiev, O. A. Korkunova, G. Z. Mukhutdinova, P. V. Tkacheva, M. M. Suleymanova, A. N. Shapieva, D. M. Ramazanova, M. N. Rzayev, V. A. Gombolevsky | ||
| "... index based on ultra-low-dose computed tomography (ultra-LDCT) which used in Moscow Lung Cancer ..." | ||
| 1 - 100 of 444 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
